Lonza bYlok
Lonza bYlok
Revolutionary Cancer Treatment: Lonza and Qurient Unite!
🌟 Lonza's Synaffix and Qurient Therapeutics unite for dual-payload ADCs, enhancing cancer treatment with innovative cytotoxic agents! 💊🔬🚀
Lonza and RION Join Forces for Exosome Breakthrough!
🌟 Exciting collaboration! Lonza and RION are set to enhance exosome-based therapeutics manufacturing for innovative, affordable global treatments. 🌍💊🔬
Lonza Partners with CMAC for Advanced Drug Manufacturing
🌟 Lonza joins CMAC in Glasgow! This partnership boosts particle technology and enhances drug manufacturing efficiency. 🤝💊 PharmaInnovation ContinuousManufacturing
Revolutionary Needle-Free mRNA Vaccines for Flu!
🌟 Ethris and Lonza team up for room-temperature stable, spray-dried mRNA vaccines targeting respiratory diseases. 💉 Needle-free, efficient distribution! 🌍🚀
Exogenus and Lonza Team Up for Groundbreaking Therapy!
🌟 Exogenus Therapeutics partners with Lonza for GMP-compliant Exo-101 process. Promising treatment for tissue regeneration and inflammation! 🔬🤝
Revolutionary Nasal Treatments: Iconovo and Lonza Team Up!
🌟 Exciting news! Iconovo and Lonza join forces to develop innovative intranasal biologics for patient-friendly therapies. 🤝💡📉
Revolutionizing Bispecific Antibody Production Made Easy!
🌟 Discover how custom manufacturers optimize bispecific antibody production, enhancing outcomes with innovative tech and early screening strategies! 🔬💡🚀
